1Stefan-Jochl3erger MD,Morgenthaler NG,Mayr VD,et al.Assay for the measurement of copeptin,a stable peptide derived from the precursor of vasopressin[J].Clin Chem,2006,52(1):112-119.
2Balanescu S,Kopp P,Gaskill MB.Correlation of plasma copeptir and vasopressin concentrations inhypo-,iso-,and hyperosmolar States[J].J Clin Endocrinol Metab,2011,96(4):1046-1052.
3Mar Masiá,Jana Papassotiriou,Nils G.Midregional Pro-A-Type Natriuretic Peptide and Carboxy-Terminal Provasopressin May Predict Prognosis in Community-Acquired Pneumonia[J].Clinical Chemistry.2007,53:2193-2201.
4Kruger S,Ewig S,Kunde J.C-terminal provasopressin(copeptin)in patients with community-acquired pneumonia-influence of antibiotic pre-treatment:results from the German competence network CAPNETZ[J].J Antimicrob Chemother,2009,64(1):159-62.
6Jochberger S,Dorler J,Luckner G.The vasopressin and copeptin response to infection,severe sepsis,and septic shock[J].Crit Care Med,2009,37(2):476-482.
7Stolz D,Christ-Crain M,Morgenthaler NG.Copeptin,C-reactive protein,and procalcitonin as prognostic biomarkers in acute exacerbation of COPD[J].Chest,2007,131(4):1058-67.
8Antonescu-Turcu AL,Tomic R.C-reactive protein and copeptin:prognostic predictors in chronic obstructive pulmonary disease exacerbations[J].Curr Opin Pulm Med,2009,15(2):120-5.
2Hupf H, Grimm D, Schunkert H, et al. Evidence for a vasopressin system in the rat heart. Circ Res. 1999,29:35.
3Valli G, Fedeli A, Palange P, et al. Water and sodium imbalance in COPD patients. Monaldi Arch Chest Dis. 2004,61 (2) :112.
4Friedmann AS. , Mallot KA. , North WG. , et al. Products of vasopressin gene expression in small - cell carcinoma of the lung. Br J Cancer. 1994,69:260.
5Morgenthaler NG, Struck J, Bergmann A, et al. Assay for the measurement of copeptin, a stable peptlde derived from the precursor of vasopressin. Clin Chem. 2006,52(1) :112.
6Struck J, Morgenthaler NG, Bergmann A. Copeptin, a stable peptide derived from the vasopressin precursor, is elevated in serum of sepsis patients. Peptides. 2005,26(12) :2500.
7Jochberger S, Morgenthaler NG, Du nser MW, et al. Copaptin and arglnine vasopressin concentrations in critically ill patients. J Clin Endocrinol Metab. 2006,91(11) :4381.
8Jochbergcr S, Luckner G, Morgenthaler NG, et al. Course of vasopressin and copeptin plasma concentrations in a patient with pevere septic shock. Anaesth Intensive Care. 2006,34 (4) :498.
9Stolz D, Christ - Crain M, Miedinger D, et al. Copeptin, C - reactive protein, and procalcitonin as prognostic biomarkers in acute exaceabation of COPD. Chest. 2007,131 (4) :1058.
10Khan SQ, Dhillon OS, Quinn PA, et al. C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study. Circulation. 2007,115 (16) :2103.
